Design of a new multiple-unit controlled-release formulation of metoprolol — Metoprolol CR A. SandbergG. RagnarssonJ. Sjögren OriginalPaper Pages: S3 - S7
Pharmacokinetic and pharmacodynamic properties of a new controlled-release formulation of metoprolol: A comparison with conventional tablets A. SandbergI. BlomqvistP. Lundborg OriginalPaper Pages: S9 - S14
Pharmacokinetic and pharmacodynamic comparison of a new controlled-release formulation of metoprolol with a traditional slow-release formulation B. OosterhuisJ. H. G. JonkmanF. A. Kerkhof OriginalPaper Pages: S15 - S18
Pharmacokinetics and pharmacodynamics of controlled-release metoprolol: A comparison with atenolol I. BlomqvistG. WestergrenP. Lundborg OriginalPaper Pages: S19 - S24
Controlled-release metoprolol compared with atenolol in asthmatic patients: Interaction with terbutaline C. -G. LöfdahlC. DahlöfN. Svedmyr OriginalPaper Pages: S25 - S32
Effect of controlled-release metoprolol on blood pressure and exercise heart rate in hypertension: A comparison with conventional tablets L. RydénB. E. KristenssonG. Westergren OriginalPaper Pages: S33 - S37
Efficacy and tolerability of a new controlled-release formulation of metoprolol: A comparison with conventional metoprolol tablets in mild to moderate hypertension J. J. R. HoutzagersJ. G. SmildeG. Westergren OriginalPaper Pages: S39 - S44
The antianginal efficacy and tolerability of controlled-release metoprolol once daily: A comparison with conventional metoprolol tablets twice daily K. EgstrupT. GundersenB. Lundgren OriginalPaper Pages: S45 - S49